Back to Virginia

HB1182 • 2026

Health insurance; coverage for contraceptive drugs & devices, including over-the-counter.

An Act to amend and reenact §§ 38.2-3407.5:1 and 38.2-3407.5:2 of the Code of Virginia, relating to health insurance; coverage for contraceptive drugs and devices.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Thomas
Last action
2026-04-22
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Health insurance; coverage for contraceptive drugs & devices, including over-the-counter.

Health insurance; coverage for contraceptive drugs and devices.

What This Bill Does

  • Health insurance; coverage for contraceptive drugs and devices.
  • Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices approved by the U.S.
  • Food and Drug Administration, including those available over-the-counter.
  • The bill prohibits a health insurance carrier from imposing upon any person receiving prescription contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HB1182G

2026-04-11 • Governor

Governor's Recommendation

Plain English: (HB1182) GOVERNOR'S RECOMMENDATION 1.

  • (HB1182) GOVERNOR'S RECOMMENDATION 1.
  • Line 48, enrolled, after claim insert or an exceptions form for coverage of non-preferred products with no cost sharing 2.
  • Line 48, enrolled, after in strike the remainder of line 48 and through single on line 49 insert at least one 3.
  • Line 49, enrolled, after plans strike available
HB1182AHC1

2026-02-04 • Committee

Subcommittee #1 Subcommittee Amendment

Plain English: 2/04/2026 HB 1182 SUBCOMMITTEE 1.

  • 2/04/2026 HB 1182 SUBCOMMITTEE 1.
  • Line 33, introduced, after over-the-counter , insert with or without a prescription,
HB1182AH1

2026-02-05 • Committee

Labor and Commerce Amendment

Plain English: 2/05/2026 HB 1182 LABOR AND COMMERCE 1.

  • 2/05/2026 HB 1182 LABOR AND COMMERCE 1.
  • Line 33, introduced, after over-the-counter , insert with or without a prescription,

Bill History

  1. 2026-04-22 Governor

    Governor's recommendation adopted

  2. 2026-04-22 House

    Signed by Speaker

  3. 2026-04-22 Senate

    Signed by President

  4. 2026-04-22 Governor

    Approved by Governor-Chapter 1092 (effective 7/1/2026)

  5. 2026-04-22 House

    Reenrolled

  6. 2026-04-22 House

    Reenrolled bill text (HB1182ER2)

  7. 2026-04-22 Governor

    Acts of Assembly Chapter text (CHAP1092)

  8. 2026-04-22 House

    House concurred in Governor's recommendation (64-Y 35-N 0-A)

  9. 2026-04-22 Senate

    Senate concurred in Governor's recommendation (24-Y 15-N 0-A)

  10. 2026-04-11 Governor

    Governor's recommendation received by House

  11. 2026-04-01 House

    Fiscal Impact Statement from Department of Planning and Budget (HB1182)

  12. 2026-03-31 House

    Enrolled Bill communicated to Governor on March 31, 2026

  13. 2026-03-31 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  14. 2026-03-31 House

    Enrolled Bill communicated to Governor on March 31, 2026

  15. 2026-03-31 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  16. 2026-03-31 House

    Signed by Speaker

  17. 2026-03-31 House

    Enrolled Bill communicated to Governor on March 31, 2026

  18. 2026-03-31 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  19. 2026-03-30 Senate

    Signed by President

  20. 2026-03-30 House

    Enrolled

  21. 2026-03-30 House

    Bill text as passed House and Senate (HB1182ER)

  22. 2026-03-11 Senate

    Read third time

  23. 2026-03-11 Senate

    Read third time

  24. 2026-03-11 Senate

    Passed Senate (23-Y 17-N 0-A)

  25. 2026-03-11 Senate

    Reconsideration of Senate passage agreed to by Senate (40-Y 0-N 0-A)

  26. 2026-03-11 Senate

    Passed Senate (24-Y 16-N 0-A)

  27. 2026-03-10 Senate

    Rules suspended

  28. 2026-03-10 Senate

    Rules suspended

  29. 2026-03-10 Senate

    Passed by for the day

  30. 2026-03-10 Senate

    Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A)

  31. 2026-03-10 Senate

    Passed by for the day Block Vote (Voice Vote)

  32. 2026-03-09 Commerce and Labor

    Reported from Commerce and Labor and rereferred to Finance and Appropriations (9-Y 6-N)

  33. 2026-03-09 Finance and Appropriations

    Reported from Finance and Appropriations (10-Y 3-N 1-A)

  34. 2026-02-18 Senate

    Constitutional reading dispensed (on 1st reading)

  35. 2026-02-18 Commerce and Labor

    Referred to Committee on Commerce and Labor

  36. 2026-02-17 House

    Read third time and passed House (63-Y 34-N 0-A)

  37. 2026-02-17 House

    Fiscal Impact Statement from Department of Planning and Budget (HB1182)

  38. 2026-02-16 House

    Read second time

  39. 2026-02-16 House

    committee amendment agreed to

  40. 2026-02-16 House

    Engrossed by House as amended

  41. 2026-02-15 House

    Read first time

  42. 2026-02-13 Appropriations

    Reported from Appropriations (21-Y 1-N)

  43. 2026-02-13 Compensation and Retirement

    Subcommittee recommends reporting (6-Y 1-N)

  44. 2026-02-05 Compensation and Retirement

    Assigned HAPP sub: Compensation and Retirement

  45. 2026-02-05 Labor and Commerce

    Reported from Labor and Commerce with amendment(s) and referred to Appropriations (15-Y 7-N)

  46. 2026-02-03 Subcommittee #1

    Subcommittee recommends reporting with amendment(s) and referring to Appropriations (6-Y 3-N)

  47. 2026-01-27 Subcommittee #1

    Assigned HCL sub: Subcommittee #1

  48. 2026-01-26 House

    Fiscal Impact Statement from Department of Planning and Budget (HB1182)

  49. 2026-01-14 House

    Prefiled and ordered printed; Offered 01-14-2026 26105319D

  50. 2026-01-14 Labor and Commerce

    Referred to Committee on Labor and Commerce

Official Summary Text

Health insurance; coverage for contraceptive drugs and devices.
Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices approved by the U.S. Food and Drug Administration, including those available over-the-counter. The bill prohibits a health insurance carrier from imposing upon any person receiving prescription contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances. Additionally, the bill requires any health benefit plan that provides coverage for hormonal contraceptives to provide point-of-sale coverage without cost-sharing at in-network pharmacies for hormonal contraceptives available over-the-counter. This bill is identical to SB 361.

Current Bill Text

Read the full stored bill text
An Act to amend and reenact §§
38.2-3407.5:1
and
38.2-3407.5:2
of the Code of Virginia, relating to health insurance; coverage for contraceptive drugs and devices.
Be it enacted by the General Assembly of Virginia:
1. That §§
38.2-3407.5:1
and
38.2-3407.5:2
of the Code of Virginia are amended and reenacted as follows:
§
38.2-3407.5:1
. Coverage for contraceptives.
A.
Each
As used in this section:
"Contraceptive device" means any device or non-drug product that has been approved as a contraceptive by the FDA.
"Contraceptive drug" means any drug approved as a contraceptive by the FDA.
"FDA" means the U.S. Food and Drug Administration.
"Medical need" includes considerations such as severity of side effects, difference in permanence and reversibility of a contraceptive drug or contraceptive device, or an ability to adhere to the appropriate use of such drug or device, as determined by an attending health care provider.
"Therapeutically equivalent version" means a drug or device that has the same clinical effect and safety profile as another drug or device and that meets the criteria for therapeutic equivalence as determined by the FDA.
B. Notwithstanding the provisions of §
38.2-3419
, each
(i) insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical or major medical coverage on an expense incurred basis; (ii) corporation providing individual or group accident and sickness subscription contracts; and (iii) health maintenance organization providing a health care plan for health care services, whose policy, contract or plan, including any certificate or evidence of coverage issued in connection with such policy, contract or plan, includes coverage for prescription drugs on an outpatient basis, shall
offer and make available
provide
coverage thereunder for
any prescribed drug or device approved by the United States Food and Drug Administration for use as a
contraceptive
drugs and contraceptive devices, including those available over-the-counter,

with or without a prescription,

in accordance with §§
38.2-3442
and
38.2-3438
.
B.
C.
No insurer, corporation
,
or health maintenance organization shall impose upon any person receiving
prescription
contraceptive benefits pursuant to this section any
(i)
copayment, coinsurance payment
,
or
fee
that is not equally imposed upon all individuals in the same benefit category, class, coinsurance level or copayment level receiving benefits for prescription drugs
, or
(ii)
reduction in allowable reimbursement for prescription drug benefits.
D. Notwithstanding the provisions of subsection C, an insurer, corporation, or health maintenance organization that provides coverage for more than one therapeutically equivalent version of a contraceptive drug or contraceptive device may impose cost-sharing requirements on any such version, provided that at least one therapeutically equivalent version of such contraceptive drug or contraceptive device is available without cost-sharing. However, if a covered individual's health care provider recommends a particular contraceptive drug or contraceptive device for such individual based on a determination of medical need, an insurer, corporation, or health maintenance organization shall provide coverage for the recommended contraceptive drug or contraceptive device without cost-sharing.
E. An insurer, corporation, or health maintenance organization to which the provisions of this section apply shall not impose any burdensome restrictions or delays on the coverage required by this section, including a requirement that a covered individual (i) obtain a prescription in order to receive coverage for contraceptive drugs and contraceptive devices available over-the-counter or (ii) make any formal request for such coverage other than a pharmacy claim
or an exceptions form for coverage of non-preferred products with no cost sharing
, and shall provide clear, written, and complete information in
at least one
location about the contraceptive coverage included and excluded from its offered plans on its website and by mail at the request of a current or potential covered individual.
C.
F.
The provisions of
subsection A
this section
shall not be construed to:
1. Require coverage for prescription coverage benefits in any contract, policy
,
or plan that does not otherwise provide coverage for prescription drugs;
or
2.
Preclude the use of closed formularies, provided, however, that such formularies shall include oral, implant and injectable contraceptive drugs, intrauterine devices and prescription barrier methods; or
3.
Require coverage for experimental
contraceptive drugs
contraceptives
not approved by the
United States Food and Drug Administration
FDA
.
D.
G.
The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans, or to short-term nonrenewable policies of not more than six months' duration.
E. The provisions of this section shall be applicable to contracts, policies or plans delivered, issued for delivery or renewed in this Commonwealth on and after July 1, 1997.
§
38.2-3407.5:2
. Reimbursements for dispensing hormonal contraceptives.
A. As used in this section:
"Covered person" means a policyholder, subscriber, enrollee, participant, or other individual covered by a health benefit plan.
"Health benefit plan" means any accident and health insurance policy or certificate, health services plan contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement (MEWA), or plan provided by another benefit arrangement. "Health benefit plan" does not mean accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplement or long-term care insurance; Medicaid coverage; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; short-term limited duration coverage; coverage issued as a supplement to liability insurance; insurance arising out of a workers' compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.
"Health carrier" means an entity subject to the insurance laws and regulations of the Commonwealth and subject to the jurisdiction of the Commission that contracts or offers to contract to provide a health benefit plan.
"Hormonal contraceptive" means a medication taken to prevent pregnancy by means of ingestion of hormones, including medications containing estrogen or progesterone, that is self-administered
, requires a prescription,
and is approved by the U.S. Food and Drug Administration for such purpose.
"Provider" means a facility, physician or other type of health care practitioner licensed, accredited, certified or authorized by statute to deliver or furnish health care items or services.
B. Any health benefit plan that is amended, renewed, or delivered on or after January 1, 2018, that provides coverage for hormonal contraceptives shall
(i)
cover up to a 12-month supply of hormonal contraceptives when dispensed or furnished at one time for a covered person by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies
and (ii) for hormonal contraceptives available over-the-counter, provide point-of-sale coverage without cost-sharing at in-network pharmacies.
C. Nothing in this section shall be construed to require a provider to prescribe, furnish, or dispense 12 months of self-administered hormonal contraceptives at one time.
D. A health benefit plan that provides coverage for hormonal contraceptives, in the absence of clinical contraindications, shall not impose utilization controls or other forms of medical management limiting the supply of hormonal contraceptives that may be dispensed or furnished by a provider or pharmacy, or at a location licensed or otherwise authorized to dispense drugs or supplies, to an amount that is less than a 12-month supply.
E. This section shall not be construed to exclude coverage for hormonal contraceptives as prescribed by a provider, acting within his scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, or for contraception that is necessary to preserve the life or health of an enrollee.
F. Nothing in this section shall be construed to require a health carrier to cover hormonal contraceptives provided by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies, that does not participate in the health carrier's provider network, except as may be otherwise authorized or required by state law or by the plan's policies governing out-of-network coverage.
2. That the provisions of this act shall apply only to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans for health care services delivered, issued for delivery, or renewed in the Commonwealth on or after January 1, 2027.